Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
116,345,357
-
Total 13F shares
-
1,865,547
-
Share change
-
-36,634
-
Total reported value
-
$2,053,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.10
-
Number of holders
-
9
-
Value change
-
-$115,802
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2022
As of 30 Jun 2022,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,865,547 shares.
The largest 9 holders included
TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, RAYMOND JAMES & ASSOCIATES, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.